Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23137321 | 1.00 | MMP3 (0.50) | MMP3TNFFLT3KMT2AKDM4E | |
| SCHEMBL30439382 | 0.92 | MMP3 (0.50) | MMP3TNFFLT3KMT2AKDM4E | |
| SCHEMBL2154504 | 0.91 | KMT2A (0.47) | MMP3TNFFLT3KMT2AKDM4E | |
| SCHEMBL343612 | 0.90 | MMP3 (0.53) | MMP3TNFFLT3KMT2AKDM4E | |
| SCHEMBL4667203 | 0.88 | MMP3 (0.67) | MMP3KMT2AABL1 | |
| SCHEMBL2773349 | 0.88 | MAOB (0.47) | MMP3TNFFLT3KMT2ARXRA | |
| SCHEMBL10899606 | 0.88 | CYP2A6 (0.52) | MMP3TNFFLT3KMT2AKDM4E | |
| SCHEMBL9925859 | 0.88 | NAAA (0.44) | MMP3TNFFLT3KMT2AL3MBTL1 | |
| SCHEMBL23578319 | 0.88 | MAOB (0.47) | MMP3TNFFLT3KMT2AL3MBTL1 | |
| SCHEMBL24067260 | 0.86 | TNF (0.54) | MMP3TNFFLT3KMT2APIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119019650-A | Sp (sp)2C covalent organic framework photo-catalytic material and preparation method and application thereof | 南京师范大学 | 2024-11-26 | — | — | CN | claimed |
| EP-4569559-A1 | GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES | Wisconsin Alumni Research Foundation (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-119019650-A | Sp (sp)2C covalent organic framework photo-catalytic material and preparation method and application thereof | 南京师范大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-119019650-A | Sp (sp)2C covalent organic framework photo-catalytic material and preparation method and application thereof | 南京师范大学 | 2024-11-26 | — | — | CN | disclosed |
| US-20240055638-A1 | GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2024-02-15 | — | — | US | disclosed |
| WO-2024036130-A1 | GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2024-02-15 | — | — | WO | disclosed |
| US-11858814-B2 | Reticulation of macromolecules into crystalline networks | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-01-02 | — | — | US | disclosed |
| CN-117186412-A | Silsesquioxane fluorescent porous hybrid polymer with D-A structure, preparation method thereof and application thereof in gold recovery | 山东大学 | 2023-12-08 | — | — | CN | disclosed |
| CN-113813939-B | Application of COF material based on C ═ C bond connection in preparation of chiral chromatography stationary phase | 上海交通大学 | 2022-08-12 | — | — | CN | disclosed |
| CN-113813939-A | Application of COF material based on C = C bond connection in preparation of chiral chromatography stationary phase | 上海交通大学 | 2021-12-21 | — | — | CN | disclosed |
| US-20110046336-A1 | TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED | 2011-02-24 | — | — | US | disclosed |
| US-20100292481-A1 | METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED | 2010-11-18 | — | — | US | disclosed |
| EP-2233459-A1 | METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20100184978-A1 | BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-22 | — | — | US | disclosed |
| EP-2192124-A1 | TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND WITH THE TRANSITION METAL COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2010-06-02 | — | — | EP | disclosed |
| EP-2172470-A1 | BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-7514158-B2 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2009-04-07 | — | — | US | disclosed |
| US-7419727-B2 | Organic electroluminescent device | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2008-09-02 | — | — | US | disclosed |
| US-20060192473-A1 | Organic electroluminescent device | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2006-08-31 | — | — | US | disclosed |
| US-20050275341-A1 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046336-A1 | TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | C9, C5, AP1M1 | MMP3 4526/4885TNF 3648/4885FLT3 1832/4885 |
| US-20100184978-A1 | BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | C9, C5, AP2M1 | MMP3 4630/4885TNF 3199/4885FLT3 2066/4885 |
| US-20050275341-A1 | Coumarin compound | XPO1, VKORC1, XPO5 | MMP3 1440/4885TNF 3365/4885FLT3 2658/4885 |
| US-20100292481-A1 | METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND | TYR, PAH, AHR | MMP3 4042/4885TNF 3076/4885FLT3 2150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.